| Application no. and date | 23202190.7 (espacenet) (Federated) (European Patent Register), 20140826 | | Patent/reg. no. and date | DK/EP 4321157, 20241023 | | Publication date | 20240214 | | Priority no. and date | WO PCT/US2013/056680, 20130826, US 201461972933 P, 20140331 | | EP pub. no. and date |
EP 4321157 20240214 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V484922DK00 | | Inventor | SHI, Victor Chengwei,
New Jersey, US,
LEFKOWITZ, Martin,
New Jersey, US,
RIZKALA, Adel Remond,
New Jersey, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/194 (2006.01) , A61K 31/197 (2006.01) , A61K 31/216 (2006.01) , A61K 31/221 (2006.01) , A61K 31/225 (2006.01) , A61K 31/401 (2006.01) , A61K 31/41 (2006.01) , A61K 45/06 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | | Title | NY ANVENDELSE AF EN KOMBINATION AF EN ANGIOTENSINRECEPTORBLOKKER (ARB) MED EN NEUTRAL ENDOPEPTIDASEHÆMMER (NEPI) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
